Model-informed Drug Development in Oncology (advanced) Apply here for DDMoRe Oncology (advanced) http://www.ddmore.eu/projects/model-informed-drug-development-oncology-advanced
The DDMoRe consortium concludes the series of comprehensive face-to-face courses with the first advanced course introducing the principles of model-informed drug development, covering a range of therapeutic areas, via the newly-developed DDMoRe interoperability framework platform. The Bioinformatics, Mathematical Modeling and Synthetic Biology (BMS) lab at Università degli Studi di Pavia, Italy and the Institute of Pharmacy, Freie Universitaet Berlin, Germany are happy to invite you to the following face-to-face course: "Model-informed Drug Development in Oncology (advanced)" Dates: 4-8 July 2016 Venue: Departement of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Via Ferrata 5, Pavia, Italy Intended for: PhD students and Postdoctoral fellows doing research in the quantitative life sciences field as well as other scientists in the field. Topics: Model-informed drug development in the area of oncology with a 2-day and half introduction to the DDMoRe platform (new modelling & simulation language, model repository, interoperability framework) and 2-day and half application of the DDMoRe platform to therapeutic area oncology Program: Lectures, hands-on sessions, group work, workshops, and participant presentations Course directors: Charlotte Kloft (Freie Universitaet Berlin, Germany), Paolo Magni (Università degli Studi di Pavia, Italy), Zinnia Parra-Guillén (Freie Universitaet Berlin, Germany/University of Navarra, Pamplona, Spain), Lorenzo Pasotti (Università degli Studi di Pavia, Italy) Prerequisites: * Willing to actively participate in the course and give constructive feedback to further improve the DDMoRe products and developments * Able to bring along a laptop that fulfils the minimum IT environment requirements specified here. Fee: Free of charge (transport, accommodation and food not included) Maximum number of participants: 20 (If needed selection based on the registration information, with priority to PhD students/post-docs and participants from different institutions). Application deadline: 25th May 2016 (Notification of acceptance 31st May 2016) Contact: [email protected]<mailto:[email protected]> For more information: * DDMoRe and the 'education & training activities': http://www.ddmore.eu * BMS lab: http://lab-bioinfo.unipv.it * About the Clinical Pharmacy group at the FU Berlin: http://www.bcp.fu-berlin.de/pharmazie/klinische_pharmazie/arbeitsgruppe_kloft/index.html * UNIPV: http://www.unipv.it We warmly invite you to join us for the last public DDMoRe course: be the first trained for using the most advanced DDMoRe products! Please download and save the application form on the DDMoRe web page, before you fill-in and submit to: [email protected]<mailto:[email protected]> ________________________________ AstraZeneca UK Limited is a company incorporated in England and Wales with registered number:03674842 and its registered office at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA. This e-mail and its attachments are intended for the above named recipient only and may contain confidential and privileged information. If they have come to you in error, you must not copy or show them to anyone; instead, please reply to this e-mail, highlighting the error to the sender and then immediately delete the message. For information about how AstraZeneca UK Limited and its affiliates may process information, personal data and monitor communications, please see our privacy notice at www.astrazeneca.com<https://www.astrazeneca.com>
